Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5617
Gene Symbol: PRL
PRL 		0.010 AlteredExpression disease BEFREE In addition, Prolactin could increase serum 1,25(OH)2D3 and ALP levels and decrease tibia BMD significantly without any change in PTH level. 30599794 2019
Entrez Id: 27295
Gene Symbol: PDLIM3
PDLIM3 		0.010 AlteredExpression disease BEFREE In addition, Prolactin could increase serum 1,25(OH)2D3 and ALP levels and decrease tibia BMD significantly without any change in PTH level. 30599794 2019
Entrez Id: 250
Gene Symbol: ALPP
ALPP 		0.010 AlteredExpression disease BEFREE In addition, Prolactin could increase serum 1,25(OH)2D3 and ALP levels and decrease tibia BMD significantly without any change in PTH level. 30599794 2019
Entrez Id: 80150
Gene Symbol: ASRGL1
ASRGL1 		0.010 AlteredExpression disease BEFREE In addition, Prolactin could increase serum 1,25(OH)2D3 and ALP levels and decrease tibia BMD significantly without any change in PTH level. 30599794 2019
Entrez Id: 6722
Gene Symbol: SRF
SRF 		0.010 Biomarker disease BEFREE Recurrence of SRF Post Intravitreal Ranibizumab for Pediatric Choroidal Neovascularisation Secondary to Best Disease. 31509457 2019
Entrez Id: 26033
Gene Symbol: ATRNL1
ATRNL1 		0.010 AlteredExpression disease BEFREE In addition, Prolactin could increase serum 1,25(OH)2D3 and ALP levels and decrease tibia BMD significantly without any change in PTH level. 30599794 2019
Entrez Id: 55226
Gene Symbol: NAT10
NAT10 		0.010 AlteredExpression disease BEFREE In addition, Prolactin could increase serum 1,25(OH)2D3 and ALP levels and decrease tibia BMD significantly without any change in PTH level. 30599794 2019
Entrez Id: 26155
Gene Symbol: NOC2L
NOC2L 		0.010 Biomarker disease BEFREE NIR-AF imaging can identify the pre-vitelliform stage of BVMD. 31070670 2019
Entrez Id: 470
Gene Symbol: ATHS
ATHS 		0.010 AlteredExpression disease BEFREE In addition, Prolactin could increase serum 1,25(OH)2D3 and ALP levels and decrease tibia BMD significantly without any change in PTH level. 30599794 2019
Entrez Id: 5741
Gene Symbol: PTH
PTH 		0.010 AlteredExpression disease BEFREE In addition, Prolactin could increase serum 1,25(OH)2D3 and ALP levels and decrease tibia BMD significantly without any change in PTH level. 30599794 2019
Entrez Id: 10850
Gene Symbol: CCL27
CCL27 		0.010 AlteredExpression disease BEFREE In addition, Prolactin could increase serum 1,25(OH)2D3 and ALP levels and decrease tibia BMD significantly without any change in PTH level. 30599794 2019
Entrez Id: 65057
Gene Symbol: ACD
ACD 		0.010 Biomarker disease BEFREE For a 3-spray strategy, the best disease control was consistently obtained with strategy ACD. 29885027 2019
Entrez Id: 6590
Gene Symbol: SLPI
SLPI 		0.010 AlteredExpression disease BEFREE In addition, Prolactin could increase serum 1,25(OH)2D3 and ALP levels and decrease tibia BMD significantly without any change in PTH level. 30599794 2019
Entrez Id: 654
Gene Symbol: BMP6
BMP6 		0.010 AlteredExpression disease BEFREE BMP6 serum levels and elbow flexion) or dystrophin levels (e.g.TIMP2) in BMD patients. 29682908 2018
Entrez Id: 7077
Gene Symbol: TIMP2
TIMP2 		0.010 AlteredExpression disease BEFREE BMP6 serum levels and elbow flexion) or dystrophin levels (e.g.TIMP2) in BMD patients. 29682908 2018
Entrez Id: 7273
Gene Symbol: TTN
TTN 		0.010 Biomarker disease BEFREE The concentration was significantly higher in DMD than in BMD patients who had significantly higher urinary titin than normal. 29175173 2018
Entrez Id: 407031
Gene Symbol: MIR30C1
MIR30C1 		0.010 AlteredExpression disease BEFREE Our results show that the serum levels of miR-30c and miR-181a increased 7- and 6-fold respectively in DMD patients (n = 21, 2-14 years, ambulant), and 7-fold in BMD patients (n = 5, 9-15 years) compared to controls (n = 22, 2-14 years). 27979502 2017
Entrez Id: 103
Gene Symbol: ADAR
ADAR 		0.010 AlteredExpression disease BEFREE Among patients with lymph node metastasis, those with high tumour-infiltrating lymphocyte levels and low ADAR1 expression demonstrated the best disease-free survival. 29022489 2017
Entrez Id: 6299
Gene Symbol: SALL1
SALL1 		0.010 Biomarker disease BEFREE TBS (Vex excluded) values decreased steadily with age with an overall loss of 8.99% between 52.5 and 77.5 years. 27900426 2017
Entrez Id: 407032
Gene Symbol: MIR30C2
MIR30C2 		0.010 AlteredExpression disease BEFREE Our results show that the serum levels of miR-30c and miR-181a increased 7- and 6-fold respectively in DMD patients (n = 21, 2-14 years, ambulant), and 7-fold in BMD patients (n = 5, 9-15 years) compared to controls (n = 22, 2-14 years). 27979502 2017
Entrez Id: 6462
Gene Symbol: SHBG
SHBG 		0.010 AlteredExpression disease BEFREE As SHBG level increased, the prevalence of osteopenia or osteoporosis defined by BMD significantly increased (OR of 1SD change, 1.24). 27873076 2017
Entrez Id: 9104
Gene Symbol: RGN
RGN 		0.010 Biomarker disease BEFREE The bones of SMP30/GNL KO mice were rough and porous, with BMC and BMD significantly below wild-type. 28448089 2017
Entrez Id: 127933
Gene Symbol: UHMK1
UHMK1 		0.010 GeneticVariation disease BEFREE One locus on 1q23 (UHMK1, rs16863247, P=4.1×10(-7) for femoral neck BMD and P=3.2×10(-6) for total hip BMD) was a novel BMD signal. 27424934 2016
Entrez Id: 659
Gene Symbol: BMPR2
BMPR2 		0.010 GeneticVariation disease BEFREE Multifactor dimensionality reduction for interactions among genes revealed a 4-locus model of BMPR-2 rs6717924G/A; ALK-1 rs11169953C/T-rs706816T/C and 5-HTT rs6354A/C as the best disease predicting (P≤0.001); whereas HapEvolution analysis confirmed the alleles rs6717924A, rs4303700A and rs6354C as the best interacting (P≤0.01). 27196063 2016
Entrez Id: 84870
Gene Symbol: RSPO3
RSPO3 		0.010 GeneticVariation disease BEFREE We also identified a new spine BMD signal in RSPO3, rs577721086 (freq. 26733130 2016